Pharma
What new PBM reforms mean for pharma
Congress passed a number of new rules for PBMs in a government funding package.
PBMs (Pricing)
Analysis of PBMs pricing, exploring the key drivers, future outlook, and impact of this critical sector on the broader healthcare industry.
Pharma
Eli Lilly switches from Big 3 PBM to alternative transparent rival
The drugmaker has about 23,000 employees who will be covered by Rightway.
Pharma
FTC halts PBM lawsuit
The commission says it doesn’t have enough people to work on the case after Trump’s administration fired two Democratic members.
Pharma
Pharma leaders talk the biggest trends of 2024
From GLP-1s to PBMs, these execs give their thoughts.
Pharma
Diabetes advocates back FTC lawsuit against PBMs
Diabetes advocates are concerned about the rising cost of insulin.
Pharma
FTC sues PBMs, alleging they artificially inflated insulin costs
The PBMs are a main culprit behind soaring insulin costs, the agency alleges.
Pharma
Drugs left off PBM lists can lead to worse patient outcomes, higher costs
The top three PBMs each excluded roughly 600 drugs from their 2023 formularies.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
